LU79591A1 - Verfahren zur herstellung von benzimidazol-derivaten - Google Patents
Verfahren zur herstellung von benzimidazol-derivatenInfo
- Publication number
- LU79591A1 LU79591A1 LU79591A LU79591A LU79591A1 LU 79591 A1 LU79591 A1 LU 79591A1 LU 79591 A LU79591 A LU 79591A LU 79591 A LU79591 A LU 79591A LU 79591 A1 LU79591 A1 LU 79591A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- preparation
- benzimidazole derivatives
- benzimidazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB18438/77A GB1595316A (en) | 1977-05-03 | 1977-05-03 | 4-(3-amino-2-hydroxy-propoxy)-benzimidazole derivatives and pharmaceutical compositions containing them |
GB4915677 | 1977-11-25 | ||
GB220878 | 1978-01-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
LU79591A1 true LU79591A1 (de) | 1979-06-13 |
Family
ID=27254036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU79591A LU79591A1 (de) | 1977-05-03 | 1978-05-03 | Verfahren zur herstellung von benzimidazol-derivaten |
Country Status (18)
Country | Link |
---|---|
JP (1) | JPS53135979A (da) |
AR (2) | AR220335A1 (da) |
AU (1) | AU3569678A (da) |
DE (1) | DE2819458A1 (da) |
DK (1) | DK190378A (da) |
ES (1) | ES469353A1 (da) |
FI (1) | FI781349A (da) |
FR (1) | FR2399414A1 (da) |
GR (1) | GR73669B (da) |
IL (1) | IL54591A0 (da) |
IT (1) | IT1096276B (da) |
LU (1) | LU79591A1 (da) |
MC (1) | MC1192A1 (da) |
NL (1) | NL7804794A (da) |
NO (1) | NO781556L (da) |
NZ (1) | NZ187066A (da) |
PT (1) | PT67980A (da) |
SE (1) | SE7805140L (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2801980A1 (de) * | 1978-01-18 | 1979-07-19 | Boehringer Mannheim Gmbh | 4-hydroxy-2-benzimidazolin-thion- derivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel |
EP0003758A1 (de) * | 1978-02-09 | 1979-09-05 | Ciba-Geigy Ag | Verätherte Hydroxy-benzodiheterocyclen und ihre Säureadditionssalze, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate |
DE2905877A1 (de) * | 1979-02-16 | 1980-08-28 | Boehringer Mannheim Gmbh | Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
CH661501A5 (fr) * | 1982-01-26 | 1987-07-31 | Oreal | Composes derivant du amino-3 propanol-2 utilisables pour la teinture des cheveux, leur procede de preparation, composition de teinture les contenant et procede de teinture de cheveux correspondant. |
DE3839743A1 (de) * | 1988-11-25 | 1990-05-31 | Hoechst Ag | Verfahren zur herstellung von benzimidazolonen |
US9784726B2 (en) | 2013-01-08 | 2017-10-10 | Atrogi Ab | Screening method, a kit, a method of treatment and a compound for use in a method of treatment |
GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB202205895D0 (en) | 2022-04-22 | 2022-06-08 | Atrogi Ab | New medical uses |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1058822A (en) * | 1963-07-30 | 1967-02-15 | Ici Ltd | 3-amino-2-hydroxypropoxy heterocyclic derivatives |
CH559729A5 (da) * | 1970-10-23 | 1975-03-14 | Hoechst Ag | |
US4081447A (en) * | 1975-04-09 | 1978-03-28 | Abbott Laboratories | 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof |
CH624395A5 (da) * | 1976-01-08 | 1981-07-31 | Ciba Geigy Ag |
-
1978
- 1978-04-26 NZ NZ187066A patent/NZ187066A/xx unknown
- 1978-04-27 FR FR7812492A patent/FR2399414A1/fr active Pending
- 1978-04-27 IL IL54591A patent/IL54591A0/xx unknown
- 1978-05-02 PT PT67980A patent/PT67980A/pt unknown
- 1978-05-02 DK DK190378A patent/DK190378A/da not_active Application Discontinuation
- 1978-05-02 FI FI781349A patent/FI781349A/fi not_active Application Discontinuation
- 1978-05-02 JP JP5241778A patent/JPS53135979A/ja active Pending
- 1978-05-02 ES ES469353A patent/ES469353A1/es not_active Expired
- 1978-05-02 MC MC781299A patent/MC1192A1/xx unknown
- 1978-05-02 NO NO781556A patent/NO781556L/no unknown
- 1978-05-03 DE DE19782819458 patent/DE2819458A1/de not_active Withdrawn
- 1978-05-03 LU LU79591A patent/LU79591A1/de unknown
- 1978-05-03 AU AU35696/78A patent/AU3569678A/en active Pending
- 1978-05-03 IT IT23000/78A patent/IT1096276B/it active
- 1978-05-03 NL NL7804794A patent/NL7804794A/xx not_active Application Discontinuation
- 1978-05-03 SE SE7805140A patent/SE7805140L/xx unknown
- 1978-05-31 AR AR272019A patent/AR220335A1/es active
-
1979
- 1979-01-24 GR GR56130A patent/GR73669B/el unknown
- 1979-07-06 AR AR277226A patent/AR219173A1/es active
Also Published As
Publication number | Publication date |
---|---|
NZ187066A (en) | 1981-02-11 |
FI781349A (fi) | 1978-11-04 |
MC1192A1 (fr) | 1979-02-23 |
SE7805140L (sv) | 1978-11-04 |
IT1096276B (it) | 1985-08-26 |
FR2399414A1 (fr) | 1979-03-02 |
GR73669B (da) | 1984-03-28 |
AR219173A1 (es) | 1980-07-31 |
DK190378A (da) | 1978-11-04 |
PT67980B (da) | 1980-05-05 |
NO781556L (no) | 1978-11-06 |
AU3569678A (en) | 1979-11-08 |
IL54591A0 (en) | 1978-07-31 |
PT67980A (en) | 1978-06-01 |
IT7823000A0 (it) | 1978-05-03 |
NL7804794A (nl) | 1978-11-07 |
AR220335A1 (es) | 1980-10-31 |
ES469353A1 (es) | 1980-01-01 |
JPS53135979A (en) | 1978-11-28 |
DE2819458A1 (de) | 1978-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DD138210A5 (de) | Verfahren zur herstellung von imidazolderivaten | |
DD138313A5 (de) | Verfahren zur herstellung von alkenderivaten | |
DD138544A5 (de) | Verfahren zur herstellung von cyclopropanderivaten | |
DD137355A5 (de) | Verfahren zur herstellung von phthalazin-derivaten | |
DD137231A5 (de) | Verfahren zur herstellung von cephemderivaten | |
DD138423A5 (de) | Verfahren zur herstellung von cephemderivaten | |
DD134526A5 (de) | Verfahren zur herstellung von alkyloxinderivaten der 7-aminothiazolylazetamidozephalosporansaeure | |
DD133950A5 (de) | Verfahren zur herstellung von morphinderivaten | |
DD133803A1 (de) | Verfahren zur herstellung von furokumarinen | |
DD137225A5 (de) | Verfahren zur herstellung von 1,2,4-triazin-5-on-derivaten | |
DD134090A5 (de) | Verfahren zur herstellung von pyridinylaminoalkylaether | |
DD137595A5 (de) | Verfahren zur herstellung von farbstoffen | |
DD135905A5 (de) | Verfahren zur herstellung von harnstoffderivaten | |
LU79591A1 (de) | Verfahren zur herstellung von benzimidazol-derivaten | |
ATA392577A (de) | Verfahren zur herstellung von acylcyaniden | |
DD135081A5 (de) | Verfahren zur herstellung von morphinderivaten | |
DD132429A5 (de) | Verfahren zur herstellung von derivaten von phenoxyalkansaeuren | |
LU79293A1 (de) | Verfahren zur herstellung von chinazolin-derivaten | |
DD138978A5 (de) | Verfahren zur herstellung von 2-oxazolidon-derivaten | |
ATA392477A (de) | Verfahren zur herstellung von acylcyaniden | |
DD130144A5 (de) | Verfahren zur herstellung von benzoylcyanid | |
ATA55178A (de) | Verfahren zur herstellung von 1alpha-hydroxy- -cholesterin-derivaten | |
DD134100A5 (de) | Verfahren zur herstellung von lactamen | |
DD135504A5 (de) | Verfahren zur herstellung von farbstoffen | |
DD138547A5 (de) | Verfahren zur herstellung von 2-guanidinomethyl-indolinen |